BlackRock’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

BlackRock’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,958,676	Closed	-$554M	–	5265
2020 Q3	$554M	Sell	3,958,676 -321,788	-8%	-$39.2M	0.02%	694
2020 Q2	$322M	Buy	4,280,464 +682,458	+19%	+$35.7M	0.01%	1004
2020 Q1	$103M	Buy	3,598,006 +2,318,002	+181%	+$60M	0.01%	1624
2019 Q4	$32.1M	Buy	1,280,004 +50,584	+4%	+$1.21M	﹤0.01%	2614
2019 Q3	$21.4M	Buy	+1,229,420	New	+$37.2M	﹤0.01%	2775

BlackRock's LVGO Position: Q4 2020 in Review

BlackRock sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 3,958,676 shares — an estimated $554M sold.

BlackRock first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $554M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

BlackRock reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
BlackRock sold 3,958,676 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $554M.
BlackRock first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
BlackRock's Livongo Health, Inc. Common Stock position peaked at $554M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.